Literature DB >> 25093882

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.

Peter W Andrews1, Joy Cavagnaro, Joy Cavanagro2, Robert Deans3, Ellen Feigal, Ellen Feigel4, Ed Horowitz5, Armand Keating6, Mahendra Rao7, Marc Turner8, Ian Wilmut9, Shinya Yamanaka10.   

Abstract

Mesh：

Year:  2014        PMID： 25093882     DOI： 10.1038/nbt.2973

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  14 in total

1.  Induced pluripotent stem cells: past, present, and future.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

2.  Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.

Authors:  Melissa K Carpenter; Larry A Couture
Journal:  Regen Med       Date:  2010-07       Impact factor: 3.806

3.  Translating stem cell research: challenges at the research frontier.

Authors:  David Magnus
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

4.  The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Justin Lowenthal; Mahendra Rao; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2013-08-29       Impact factor: 6.940

5.  Toward the development of a global induced pluripotent stem cell library.

Authors:  Marc Turner; Stephen Leslie; Nicholas G Martin; Marc Peschanski; Mahendra Rao; Craig J Taylor; Alan Trounson; David Turner; Shinya Yamanaka; Ian Wilmut
Journal:  Cell Stem Cell       Date:  2013-10-03       Impact factor: 24.633

6.  Steering a new course for stem cell research: NIH's intramural Center for Regenerative Medicine.

Authors:  Mahendra S Rao; Francis S Collins
Journal:  Stem Cells Transl Med       Date:  2012-01       Impact factor: 6.940

7.  Stem cells. U.S. regulation of stem cells as medical products.

Authors:  Douglas Sipp; Leigh Turner
Journal:  Science       Date:  2012-12-07       Impact factor: 47.728

Review 8.  Managing particulates in cellular therapy.

Authors:  Dominic Clarke; Dorit Harati; Jerold Martin; Jon Rowley; Juergen Keller; Michael McCaman; Miguel Carrion; Ohad Karnieli; Richard Maziarz; Robert Perry; Steve Oh; Jean Stanton
Journal:  Cytotherapy       Date:  2012-08-17       Impact factor: 5.414

Review 9.  Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

Authors:  Christopher A Bravery; Jessica Carmen; Timothy Fong; Wanda Oprea; Karin H Hoogendoorn; Juliana Woda; Scott R Burger; Jon A Rowley; Mark L Bonyhadi; Wouter Van't Hof
Journal:  Cytotherapy       Date:  2013-01       Impact factor: 5.414

10.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940
View more
  25 in total

Review 1.  Concise review: making and using clinically compliant pluripotent stem cell lines.

Authors:  Melissa K Carpenter; Mahendra S Rao
Journal:  Stem Cells Transl Med       Date:  2015-02-26       Impact factor: 6.940

Review 2.  New strategies for improving stem cell therapy in ischemic heart disease.

Authors:  Peisen Huang; Xiaqiu Tian; Qing Li; Yuejin Yang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

3.  Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics.

Authors:  Kaivalya Molugu; Ty Harkness; Jared Carlson-Stevermer; Ryan Prestil; Nicole J Piscopo; Stephanie K Seymour; Gavin T Knight; Randolph S Ashton; Krishanu Saha
Journal:  Biophys J       Date:  2019-10-22       Impact factor: 4.033

4.  Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.

Authors:  Xiao Han; Hongjun Li; Daojia Zhou; Zhaowei Chen; Zhen Gu
Journal:  Acc Chem Res       Date:  2020-10-19       Impact factor: 22.384

Review 5.  Moving stem cells to the clinic: potential and limitations for brain repair.

Authors:  Julius A Steinbeck; Lorenz Studer
Journal:  Neuron       Date:  2015-04-08       Impact factor: 17.173

6.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

Review 7.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

Review 8.  Hurdles to clinical translation of human induced pluripotent stem cells.

Authors:  Evgenios Neofytou; Connor Galen O'Brien; Larry A Couture; Joseph C Wu
Journal:  J Clin Invest       Date:  2015-07-01       Impact factor: 14.808

9.  Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan.

Authors:  Takashi Nakano; Yasuhiro Katayama; Michiharu Sakamoto; Yoshihiro Shimizu; Masukazu Inoie; Norio Shimizu; Hiroki Yamanaka; Itaru Tsuge; Susumu Saito; Naoki Morimoto
Journal:  J Artif Organs       Date:  2022-05-05       Impact factor: 1.731

Review 10.  The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.

Authors:  Marc C Hansel; Julio C Davila; Massoud Vosough; Roberto Gramignoli; Kristen J Skvorak; Kenneth Dorko; Fabio Marongiu; William Blake; Stephen C Strom
Journal:  Curr Protoc Toxicol       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.